Blood cancer patient study at Assiut University
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at the characteristics and outcomes of adults with blood cancers (hematological malignancies) treated at Assiut University. It helps doctors understand how different blood cancers affect people and what treatments work best.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a blood cancer (like leukemia, lymphoma, or multiple myeloma).
- You are being diagnosed and treated at Assiut University.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at survival rates for people treated for gynecologic cancers at Assiut University. It aims to understand how well treatments work for different types of gynecologic cancers.
This study is looking at children with acquired aplastic anemia in the Assiut area in Egypt. It aims to understand more about the disease and how it affects children. If your child fits the criteria, joining could help improve care for others with this condition.
This study follows adults who are being checked for a possible blood cancer, or who were recently diagnosed with a blood cancer within the last 6 months. It may help doctors understand the condition better and improve how early workups and care are organized.
This trial looks at blood types (ABO and Rh) in people newly diagnosed with acute leukemia. It may help doctors understand if certain blood types are more common in these patients.
This study tests a new way to check how blood cancers respond to immunotherapy. It looks at small blood or bone marrow samples before and during treatment to help doctors choose the best therapy.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
Hear when a new Haematologic Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.